Section I
1 – 10 of 5146
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2026
-
Mark
Chemoradiation Therapy Versus Radiation Therapy Alone in T1-2 Oropharyngeal Cancer With Low-Volume Neck Disease: A Population-Based Cohort Study Using the Swedish Head and Neck Cancer Register
- Contribution to journal › Article
-
Mark
Not All Tumors Are Alike : Varying Efficacy of FLASH Across Tumor Types and Oxygenation Status in Spheroid Models
- Contribution to journal › Article
-
Mark
Dynamic assessment of proliferation to guide response-adapted therapy in the setting of neoadjuvant chemotherapy in ER+/HER2- breast cancer
- Contribution to journal › Article
-
Mark
Routinely collected health data on 10-year genitourinary and gastrointestinal morbidity after ultra-hypofractionated versus conventionally fractionated radiotherapy for localised prostate cancer in the randomised, non-inferiority, phase 3 trial HYPO-RT-PC
- Contribution to journal › Article
-
Mark
Dose-response relationships in neuroendocrine tumours treated with peptide receptor radionuclide therapy
(2026) In Lund University, Faculty of Medicine Doctoral Dissertation Series
- Thesis › Doctoral thesis (compilation)
-
Mark
Disease progression more than 6 years after treatment impacts overall survival in mantle cell lymphoma
- Contribution to journal › Article
-
Mark
Iron deficiency restrains short-term recovery in patients undergoing surgery for advanced ovarian cancer
- Contribution to journal › Article
-
Mark
Integrin-Piezo1 Axis Drives ECM Remodeling and Invasion of 3D Breast Epithelium
- Contribution to journal › Article
-
Mark
Restricted Expression of the Constant Region 1 of T-Cell Receptor β by Flow Cytometry Facilitates Detection of T-Cell Neoplasms With High Specificity but Moderate Predictive Value
- Contribution to journal › Article
-
Mark
Interval cancer, sensitivity, and specificity comparing AI-supported mammography screening with standard double reading without AI in the MASAI study : a randomised, controlled, non-inferiority, single-blinded, population-based, screening-accuracy trial
- Contribution to journal › Article
